Celestica (CLS) – Analysts’ Recent Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of Celestica (NYSE: CLS) in the last few weeks:

• 9/6/2026 – Celestica was downgraded by Wall Street Zen from “buy” to “hold”.
• 8/29/2026 – Celestica was downgraded by Wall Street Zen from “buy” to “hold”.
• 8/26/2026 – Celestica was given a new $450.00 price target by Royal Bank Of Canada. They now have an “outperform” rating on the stock.
• 8/24/2026 – Celestica was upgraded by UBS Group AG from “neutral” to “buy”. They now have a $430.00 price target on the stock, up from $410.00.
• 8/13/2026 – Celestica was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.
• 8/11/2026 – Celestica is now covered by Scotiabank. They set a “sector outperform” rating and a $500.00 price target on the stock.
• 8/7/2026 – Celestica had its price target lowered by Barclays PLC from $430.00 to $406.00. They now have an “overweight” rating on the stock.
• 7/30/2026 – Celestica was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
• 7/29/2026 – Celestica had its price target raised by Canadian Imperial Bank of Commerce from $480.00 to $500.00. They now have an “outperform” rating on the stock.
• 7/29/2026 – Celestica had its “buy” rating reaffirmed by Bank of America Corporation.
• 7/29/2026 – Celestica had its “neutral” rating reaffirmed by UBS Group AG. They now have a $410.00 price target on the stock.
• 7/29/2026 – Celestica had its price target lowered by Barclays PLC from $441.00 to $430.00. They now have an “overweight” rating on the stock.
• 7/29/2026 – Celestica had its price target raised by Wolfe Research from $425.00 to $475.00. They now have an “outperform” rating on the stock.
• 7/29/2026 – Celestica had its price target raised by Royal Bank Of Canada from $440.00 to $450.00. They now have an “outperform” rating on the stock.
• 7/29/2026 – Celestica had its price target raised by JPMorgan Chase & Co. from $445.00 to $485.00. They now have an “overweight” rating on the stock.
• 7/28/2026 – Celestica was given a new $500.00 price target by Stifel Nicolaus.
• 7/28/2026 – Celestica had its “buy” rating reaffirmed by BWS Financial.
• 7/16/2026 – Celestica was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.

Insider Buying and Selling at Celestica

In related news, CEO Robert Mionis sold 98,453 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total value of $36,328,172.47. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Mandeep Chawla sold 17,000 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the completion of the transaction, the chief financial officer owned 82,444 shares in the company, valued at approximately $32,948,744.60. This trade represents a 17.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 356,553 shares of company stock valued at $135,238,444 in the last quarter. 1.10% of the stock is currently owned by company insiders.

Celestica Inc (NYSE: CLS) is a global provider of design, manufacturing, and supply chain solutions for technology companies and other businesses. The company helps customers develop, manufacture, and support complex electronic products and systems, offering services that span product design and engineering, prototyping, printed circuit board assembly, systems integration, testing, supply chain management, and after-market support.

Celestica serves customers across several markets, including communications and cloud infrastructure, aerospace and defense, industrial technology, health technology, and capital equipment.